BAT Tests Find Overfilled E-Cigarette Liquids in UK Market

Mar.17.2023
BAT Tests Find Overfilled E-Cigarette Liquids in UK Market
A test by BAT found most major disposable e-cigarette brands in the UK have overfilled e-liquid, according to betterRetailing.

On March 17th, UK media outlet betterRetailing released a report on BAT (British American Tobacco) testing, which revealed that almost all major disposable e-cigarette brands in the UK had exceeded the legal limit for nicotine content in their e-liquids. This included popular UK brands such as Elfbar, LOSTMARY, SMOK, SKE Crystal, and Solo. BAT sent the results of the testing report to distributors, retailers, and regulatory bodies, urging them to ensure that non-compliant products were not supplied.


The President of UKVIA, John...


In response to this incident, 2FIRSTS conducted an email interview with the President of the UK Vaping Industry Association (UKVIA), John. The original interview in English can be accessed by clicking the provided link. The following is the full transcript of the interview.


Can you provide the English translation of "Q:2FIRSTS"? It is unclear what you are referring to.


A spokesperson for the UK Vaping Industry Association (UKVIA), John


According to a report from Better Retailing, British American Tobacco conducted testing on disposable e-cigarette liquid in the UK market and sent the results to distributors and government departments. Has the association been made aware of this news? Did British American Tobacco send the testing report to the association?


BAT has conducted numerous tests on disposable e-cigarette brands in the UK and shared its findings with various organizations, including the association. It is also known that other companies have conducted similar tests, but their results differ from those of BAT.


Do you believe that the issue of "e-cigarette e-liquid exceeding standards" is a common problem in the UK e-cigarette market?


A: Yes, based on the data we have seen, we do believe that some brands have been using excessive amounts of e-liquid to gain a competitive advantage.


Question: Will this test result regarding the excessive levels found in disposable e-cigarettes have an impact on the disposable e-cigarette market in the UK?


A: Yes, I believe this highlights issues with the MHRA approval process. I expect this process to become more rigorous. Additionally, I think major distributors should now perform their own testing on products they bring in. Non-compliant behavior is unacceptable.


Several brand dealers have said that some of the products tested by BAT are "old inventory," while the latest products are now compliant with standards. Will UKVIA test the latest products?


A: The key issue is not the inventory itself, as "old stock" is not a legitimate excuse. In fact, it's quite simple - products are either compliant or non-compliant. I believe all brands should conduct regular testing to ensure they are following the rules. The association will not protect those who break the law.


Q: Has BAT been in contact with the association and asked them to take measures?


Yes, we have had multiple discussions with BAT regarding this issue. If the MHRA and trade transaction standards are the regulators and enforcers in this matter, we will work with both institutions to ensure that the products sold in the UK are legal. The association will also protect its good reputation.


Special Statement: The above content is a translated article, for accurate interpretation please refer to the original English version.


Click here to read the original article in English: UKVIA responds to overfill incident, alleging that BAT's findings contradict tests conducted by other companies.


Further reading:


Content summary of the ELFBAR over-the-limit e-liquid incident in the UK.


British media reports obtaining BAT test report: Almost all disposable e-cigarette brands in the UK have excessive e-liquid levels.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Holdings Limited will acquire 100% of PT Broad Far Indonesia through two wholly owned subsidiaries for approximately RMB 90 million. The Indonesian company manufactures and sells heat-not-burn tobacco sticks and provides OEM/ODM services. The sellers are part of a related-party group controlled by Huabao International Chair and controlling shareholder Zhu Linyao. PT Broad Far Indonesia generated $4.37 million in revenue and $177,000 in profit after tax in the first half of 2026, while net assets stood at about $326,000 at June-end. An independent valuer assessed the company’s equity at approximately RMB 93.06 million. Following completion, the HNB manufacturing operation will be consolidated into Huabao International.
News
Sep.29 by 2Firsts Perspectives
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24